Peer Review History

Original SubmissionSeptember 20, 2022
Decision Letter - Roberto Magalhães Saraiva, Editor

PONE-D-22-25832Association of epicardial fat with cardiac structure and function and cardiovascular outcomes: a protocol for systematic review and meta-analysisPLOS ONE

Dear Dr. Fukuta,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 13 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Roberto Magalhães Saraiva, MD, PhD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf

and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: No

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors provide an interesting and potential important manuscript describing "Association of epicardial fat with cardiac structure and function and cardiovascular

outcomes: a protocol for systematic review and meta-analysis", The main issues concerning this paper are those concerning the potential associations between epicardial fat and cardiac structure and function and cardiovascular outcomes

There are some weak points that need to be addressed by the authors.

Minor

1.In general, excess adipocytes have some negative effects on cardiovascular disease, but adipocytes, as an endocrine cell, can also secrete molecules such as adiponectin, omentin, and others that are beneficial for cardiovascular conditions. Adipose secreted factors in the context of non obesity, may play a protective role against cardiovascular. Patients older than 18 years were selected in the text for the determination of epicardial fat volume using MRI or CT and were not qualitative about whether the selected subjects were obese or not. So it is recommended to add grouping in this respect.

2.On the other hand, the age factor has a direct effect on mortality and prognosis, in order to better represent the effect of epicardial fat on CVD, the age grouping can be further increased under the premise that the data collected in the articles are comprehensive.

Reviewer #2: To my knowledge, there is no systematic literature review and meta-analysis that evaluates the association between epicardial fat and cardiac remodeling/cardiovascular events.

However, several criticisms should to be addressed:

- In the abstract, it is not clear the main aim of the study. In the secondary outcome, it is incorrect to consider the cardiac structure and dysfunction within the cardiovascular events. Furthermore, major outcomes, such as cardiovascular death and hospitalizations for HF, are already considered in the primary outcome of the study. Cardiac structure and function seems to be the main focus of the work, reading the title, but the primary objective concerns instead cardiovascular events. Clarify this aspect better.

- More details are required in the method section. Who and how many researchers will the literature search be performed? What is the combination of keywords used in the literature search? Will a hand search of references be performed upon completion? How often will the literature search be repeated?

- The authors plan to include only studies with measured cardiac structure and function on echocardiography. Could it also be useful to include studies that have measured cardiac structure and function with other less common methods, in order to have a more complete view of the literature?

- Regarding cardiovascular outcome, it is not clear why the authors want to focus their work only on heart failure?

- More details regarding the data extraction would be required.

- In the discussion section, among the possible mechanisms linking visceral fat and cardiac dysfunction, the authors cannot overlook the role of cardiac natriuretic peptides (see PMID: 36430893).

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: Response-PONE-D-22-25832_R1.doc
Revision 1

Response to Reviewers

Reviewer #1: The authors provide an interesting and potential important manuscript describing "Association of epicardial fat with cardiac structure and function and cardiovascular

outcomes: a protocol for systematic review and meta-analysis", The main issues concerning this paper are those concerning the potential associations between epicardial fat and cardiac structure and function and cardiovascular outcomes

There are some weak points that need to be addressed by the authors.

We are grateful for the comments of the reviewer, which have helped us improve our manuscript.

1.In general, excess adipocytes have some negative effects on cardiovascular disease, but adipocytes, as an endocrine cell, can also secrete molecules such as adiponectin, omentin, and others that are beneficial for cardiovascular conditions. Adipose secreted factors in the context of non obesity, may play a protective role against cardiovascular. Patients older than 18 years were selected in the text for the determination of epicardial fat volume using MRI or CT and were not qualitative about whether the selected subjects were obese or not. So it is recommended to add grouping in this respect.

As indicated, we have added the description that the subgroup analysis stratified by obese or not will be performed (page 10, para. 3, lines 1-4) and that meta-regression will be used to determine whether the association of increased epicardial fat with outcomes will be confounded by body mass index (page 10, para. 3, lines 4-6).

2.On the other hand, the age factor has a direct effect on mortality and prognosis, in order to better represent the effect of epicardial fat on CVD, the age grouping can be further increased under the premise that the data collected in the articles are comprehensive.

As indicated, we have added the description that the subgroup analysis stratified by elderly or not will be performed (page 10, para. 3, lines 1-4) and that meta-regression will be used to determine whether the association of increased epicardial fat with outcomes will be confounded by age (page 10, para.3, lines 4-6).

Reviewer #2: To my knowledge, there is no systematic literature review and meta-analysis that evaluates the association between epicardial fat and cardiac remodeling/cardiovascular events.

However, several criticisms should to be addressed:

We are grateful for the excellent review.

- In the abstract, it is not clear the main aim of the study. In the secondary outcome, it is incorrect to consider the cardiac structure and dysfunction within the cardiovascular events. Furthermore, major outcomes, such as cardiovascular death and hospitalizations for HF, are already considered in the primary outcome of the study. Cardiac structure and function seems to be the main focus of the work, reading the title, but the primary objective concerns instead cardiovascular events. Clarify this aspect better.

As indicated, we have revised the definitions of the primary and secondary outcomes (page 8, para.1, lines 1-3).

- More details are required in the method section. Who and how many researchers will the literature search be performed? What is the combination of keywords used in the literature search? Will a hand search of references be performed upon completion? How often will the literature search be repeated?

As indicated, we have revised the description of search strategy (page 6, para.2, carrying over to next page) and have added flow diagram (Fig. 1).

- The authors plan to include only studies with measured cardiac structure and function on echocardiography. Could it also be useful to include studies that have measured cardiac structure and function with other less common methods, in order to have a more complete view of the literature?

As suggested, we have revised the description of selection criteria (page 7, para. 3, lines 2-4).

- Regarding cardiovascular outcome, it is not clear why the authors want to focus their work only on heart failure?

As indicated, we have revised the definition of cardiovascular outcomes (page 8, para. 1, lines 1-3).

- More details regarding the data extraction would be required.

As indicated, we have revised the description of data extraction (page 8, para. 2, carrying over to next page).

- In the discussion section, among the possible mechanisms linking visceral fat and cardiac dysfunction, the authors cannot overlook the role of cardiac natriuretic peptides (see PMID: 36430893).

As indicated, we have discussed the role of natriuretic peptides for the possible mechanisms linking visceral fat and cardiac dysfunction (page 12, para.1, lines 4-9).

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Roberto Magalhães Saraiva, Editor

Association of epicardial fat with cardiac structure and function and cardiovascular outcomes: a protocol for systematic review and meta-analysis

PONE-D-22-25832R1

Dear Dr. Fukuta,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Roberto Magalhães Saraiva, MD, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: All the problems have been solved. The article provides the association of empirical fat with cardiac structure and function and cardiovascular outcomes, which is important for the new research

Reviewer #2: The authors satisfied my previous requests and now the manuscript is clearer. I have no further suggestions.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Roberto Magalhães Saraiva, Editor

PONE-D-22-25832R1

Association of epicardial fat with cardiac structure and function and cardiovascular outcomes: a protocol for systematic review and meta-analysis

Dear Dr. Fukuta:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Roberto Magalhães Saraiva

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .